Lunai Bioworks Inc.
LNAI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001527728
No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Lunai Bioworks Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 51 | 43 | −8 |
| Shares | 3.96M | 3.79M | −167.9K (−4.2%) |
| Value | $7.64M | $6.87M | −$773.9K (−10.1%) |
New holders (6)
Institutions that held Lunai Bioworks Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Allspring Global Investments Holdings, LLC | 37,061 | $67.0K | 0.00% |
| AQR Capital Management LLC | 25,805 | $47.0K | 0.00% |
| Bank of Montreal | 16,892 | $42.0K | 0.00% |
| Gladius Capital Management LP | 15,225 | $28.0K | 0.00% |
| Alliancebernstein L.P. | 10,400 | $19.0K | 0.00% |
| Clear Street Markets LLC | 70 | $0 | 0.00% |
Sold out (14)
Institutions that held Lunai Bioworks Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| D. E. Shaw & Co., Inc. | 64,443 | $124.0K |
| Citadel Advisors LLC | 49,034 | $94.0K |
| Susquehanna International Group, LLP | 41,073 | $79.0K |
| Cubist Systematic Strategies, LLC | 25,990 | $50.0K |
| First Trust Advisors LP | 22,776 | $44.0K |
| XTX Topco Ltd | 20,515 | $40.0K |
| Engineers Gate Manager LP | 16,414 | $32.0K |
| Atom Investors LP | 13,306 | $26.0K |
| Anson Funds Management LP | 11,215 | $22.0K |
| Boulder Hill Capital Management LP | 10,600 | $20.0K |
| Point72 Hong Kong Ltd | 7,824 | $15.0K |
| Simplex Trading, LLC | 4,372 | $8.00K |
| Group One Trading, L.P. | 3,083 | $6.00K |
| Northwestern Mutual Wealth Management Co | 1,000 | $2.00K |